Efficacy and safety of a basal insulin + 2‐3 oral antihyperglycaemic drugs regimen versus a twice‐daily premixed insulin + metformin regimen after short‐term intensive insulin therapy in individuals with type 2 diabetes: the multicentre, open‐label, randomised controlled BEYOND‐V trial

Published 2022 View Full Article

Authors

Keywords

Journal

DIABETES OBESITY & METABOLISM

Volume -, Issue -, Pages -

Publisher

Wiley

Online

2022-06-01

DOI

10.1111/dom.14780

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

DIABETES OBESITY & METABOLISM

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Ask a Question. Answer a Question.